GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » 5-Year Sharpe Ratio

Abingdon Health (LSE:ABDX) 5-Year Sharpe Ratio : N/A (As of Jul. 16, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health 5-Year Sharpe Ratio?

The 5-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past five years. As of today (2025-07-16), Abingdon Health's 5-Year Sharpe Ratio is Not available.


Competitive Comparison of Abingdon Health's 5-Year Sharpe Ratio

For the Diagnostics & Research subindustry, Abingdon Health's 5-Year Sharpe Ratio, along with its competitors' market caps and 5-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's 5-Year Sharpe Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's 5-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Abingdon Health's 5-Year Sharpe Ratio falls into.


;
;

Abingdon Health 5-Year Sharpe Ratio Calculation

The 5-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last five years. A stock / portfolio's 5-Year Sharpe Ratio can be calculated by dividing the difference between the five-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past five years.


Abingdon Health  (LSE:ABDX) 5-Year Sharpe Ratio Explanation

The 5-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past five years. It is calculated as the annualized result of the average five-year monthly excess returns divided by its standard deviation in the five-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Abingdon Health 5-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Abingdon Health's 5-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties; Contract Manufacturing comprises contract development and manufacturing activities; Regulatory Services; and Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates in the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health Headlines

No Headlines